Virolens

Virolens is a UK private diagnostics and medical device company developing and commercializing a rapid point-of-care screening instrument for infectious diseases. Its core product, the Virolens system, combines microscopic holographic imaging with artificial intelligence software to identify pathogens from oral samples in roughly 20 seconds without a central laboratory workflow. The platform was initially positioned around COVID-19 screening and broader respiratory infection detection, with messaging that it could expand to viruses, bacteria, and other infectious diseases. The company appears to operate as a small, privately held healthtech business based in Toddington, England, and has historical roots under the names iAbra and Ellcom Solutions. Overall, Virolens is best understood as an AI-enabled diagnostic device company rather than a therapeutics developer.